000			01943 a2200541 4500
005			20250516033310.0
264		0	_c20110801
008			201108s 0 0 eng d
022			_a1536-4828
024	7		_a10.1097/MPA.0b013e318214fa6c _2doi
040			_aNLM _beng _cNLM
100	1		_aWatanabe, Satoshi
245	0	0	_aHepatocyte growth factor inhibits anoikis of pancreatic carcinoma cells through phosphatidylinositol 3-kinase pathway. _h[electronic resource]
260			_bPancreas _cMay 2011
300			_a608-14 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAndrostadienes _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAnoikis _xdrug effects
650	0	4	_aAntibodies _ximmunology
650	0	4	_aBlotting, Western
650	0	4	_aCadherins _ximmunology
650	0	4	_aCell Adhesion _xdrug effects
650	0	4	_aCell Communication _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aHepatocyte Growth Factor _xpharmacology
650	0	4	_aHumans
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aPyridines _xpharmacology
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aWortmannin
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_ap38 Mitogen-Activated Protein Kinases _xantagonists & inhibitors
700	1		_aKishimoto, Takashi
700	1		_aYokosuka, Osamu
773	0		_tPancreas _gvol. 40 _gno. 4 _gp. 608-14
856	4	0	_uhttps://doi.org/10.1097/MPA.0b013e318214fa6c _zAvailable from publisher's website
999			_c20765094 _d20765094